parthenolide and Cystic Fibrosis

parthenolide has been researched along with Cystic Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, M; DiDonato, J; Li, J; Masters, S; Saadane, A1
Cabrini, G; Melotti, P; Nicolis, E; Pavirani, A; Rolfini, R; Tamanini, A1

Other Studies

2 other study(ies) available for parthenolide and Cystic Fibrosis

ArticleYear
Parthenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice.
    American journal of respiratory cell and molecular biology, 2007, Volume: 36, Issue:6

    Topics: Active Transport, Cell Nucleus; Animals; Bronchoalveolar Lavage Fluid; Cell Line; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; I-kappa B Kinase; Inflammation; Interleukin-1beta; Interleukin-8; Lipopolysaccharides; Lung; Male; Mice; Mice, Knockout; NF-kappa B; Sesquiterpenes; Tumor Necrosis Factor-alpha

2007
Activation of NF-kB mediates ICAM-1 induction in respiratory cells exposed to an adenovirus-derived vector.
    Gene therapy, 2001, Volume: 8, Issue:18

    Topics: Acetylcysteine; Adenoviridae; Antioxidants; Cell Line; Chloramphenicol O-Acetyltransferase; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Gene Expression; Genetic Therapy; Genetic Vectors; Humans; Intercellular Adhesion Molecule-1; Lung; NF-kappa B; Peptides; Pyrrolidines; RNA, Messenger; Sesquiterpenes; Thiocarbamates; Translocation, Genetic

2001